| MeSH term | MeSH ID | Detail |
|---|---|---|
| Abortion, Spontaneous | D000022 | 12 associated lipids |
| Abnormalities, Drug-Induced | D000014 | 10 associated lipids |
clarithromycin
clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.
Cross Reference
Introduction
To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with clarithromycin?
clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (63)
- J. Antimicrob. Chemother. (56)
- J. Clin. Microbiol. (39)
- Others (258)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with clarithromycin
PubChem Associated disorders and diseases
What pathways are associated with clarithromycin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with clarithromycin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- J. Antimicrob. Chemother. (25)
- Antimicrob. Agents Chemother. (20)
- J. Clin. Microbiol. (9)
- Others (66)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with clarithromycin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with clarithromycin?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (5)
- Drug Metab. Dispos. (1)
- FEMS Immunol. Med. Microbiol. (1)
- Others (5)
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with clarithromycin?
Related references are published most in these journals:
- J. Antimicrob. Chemother. (20)
- Antimicrob. Agents Chemother. (17)
- J. Clin. Microbiol. (13)
- Others (57)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with clarithromycin?
Mouse Model
Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).
Knock-out
Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).
Experimental Pneumococcal Meningitis
Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with clarithromycin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Hoigné-Löpfe I and Jöhr M | Psychiatric symptoms after anesthesia: antibiomania or Hoigné's syndrome? | 2006 | Paediatr Anaesth | pmid:16618314 |
| Przybylo HJ et al. | Acute psychosis after anesthesia: the case for antibiomania. | 2005 | Paediatr Anaesth | pmid:16029408 |
| Korppi M | Community-acquired pneumonia in children: issues in optimizing antibacterial treatment. | 2003 | Paediatr Drugs | pmid:14658923 |
| Capitano B et al. | Antibacterials for the prophylaxis and treatment of bacterial endocarditis in children. | 2001 | Paediatr Drugs | pmid:11706922 |
| Zar HJ | Neonatal chlamydial infections: prevention and treatment. | 2005 | Paediatr Drugs | pmid:15871630 |
| Shinkai M and Rubin BK | Macrolides and airway inflammation in children. | 2005 | Paediatr Respir Rev | pmid:16153572 |
| Wood N and McIntyre P | Pertussis: review of epidemiology, diagnosis, management and prevention. | 2008 | Paediatr Respir Rev | pmid:18694712 |
| Faraji F et al. | The effect of Helicobacter pylori eradication on migraine: a randomized, double blind, controlled trial. | 2012 Nov-Dec | Pain Physician | pmid:23159967 |
| Khan MK et al. | Bioequivalence study of two oral formulations of clarithromycin in human male subjects. | 2011 | Pak J Pharm Sci | pmid:21190917 |
| Fagoonee S et al. | Efficacy of cefixime-based triple therapy for Helicobacter pylori eradication: a retrospective study. | 2013 | Panminerva Med | pmid:24088806 |
| Cisarò F et al. | Ranitidine bismuth citrate in the first-line of Helicobacter pylori treatment. | 2011 | Panminerva Med | pmid:21659979 |
| Ribaldone DG et al. | Efficacy of amoxycillin and clarithromycin-based triple therapy for Helicobacter pylori eradication: a 10-year trend in Turin, Italy. | 2015 | Panminerva Med | pmid:25971330 |
| Tursi A et al. | Evaluation of the efficacy and tolerability of four different therapeutic regimens for the Helicobacter pylori eradication. | 1996 | Panminerva Med | pmid:9009677 |
| Barbon V | On the efficacy of macrolide-based therapy for Helicobacter pylori infection. | 2009 | Panminerva Med | pmid:19352310 |
| Palmas F et al. | Eradication of Helicobacter pylori infection with proton pump inhibitor-based triple therapy. A randomised study. | 2002 | Panminerva Med | pmid:12032434 |
| Tursi A et al. | Decreasing efficacy of the standard seven-day triple therapy containing amoxycillin and clarithromycin in curing Helicobacter pylori infection in clinical setting in Italy: a 10-year follow-up study. | 2014 | Panminerva Med | pmid:24637473 |
| Hemphill A et al. | Treatment of echinococcosis: albendazole and mebendazole--what else? | 2014 | Parasite | pmid:25526545 |
| Tripathi R et al. | Clarithromycin, a cytochrome P450 inhibitor, can reverse mefloquine resistance in Plasmodium yoelii nigeriensis- infected Swiss mice. | 2011 | Parasitology | pmid:21756423 |
| Pandey SK et al. | Antimalarial interaction of quinine and quinidine with clarithromycin. | 2013 | Parasitology | pmid:23137860 |
| Masuda H et al. | Characteristics and trends of clarithromycin-resistant Helicobacter pylori isolates in Japan over a decade. | 2004 | Pathobiology | pmid:15051929 |
| RodrÃguez-Sevilla G et al. | Influence of three-dimensional lung epithelial cells and interspecies interactions on antibiotic efficacy against Mycobacterium abscessus and Pseudomonas aeruginosa. | 2018 | Pathog Dis | pmid:29648588 |
| Ploy MC et al. | [Antibacterial activity of clarithromycin and its hydroxylated derivative and two other macrolides against thirty strains of Streptococcus pneumoniae]. | 1994 | Pathol. Biol. | pmid:7824300 |
| Gevaudan MJ et al. | [Evaluation of the extra- and intracellular activity of clarithromycin against Mycobacterium chelonae]. | 1994 | Pathol. Biol. | pmid:7824305 |
| Dauendorffer JN et al. | In vitro sensitivity of Mycobacterium xenopi to five antibiotics. | 2002 | Pathol. Biol. | pmid:12504367 |
| Ximenes E et al. | [Ciprofloxacin, clarithromycin, rifampin: in vitro bactericidal activity of double and triple drug combinations against strains of atypical mycobacteria]. | 1993 | Pathol. Biol. | pmid:8233629 |
| Dabernat H et al. | [in vitro activity of telithromycin against Haemophilus influenzae]. | 2002 | Pathol. Biol. | pmid:11873632 |
| Heurtin C et al. | [Comparative study of the bacteriostatic and bactericidal activity of levofloxacin against Pasteurella strains isolated from man]. | 2001 | Pathol. Biol. | pmid:11692747 |
| Mariani-Kurkdjian P et al. | [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France]. | 2004 | Pathol. Biol. | pmid:15465270 |
| Géhanno P et al. | [Clarithromycin versus amoxicillin-clavulanic acid in the treatment of acute maxillary sinusitis in adults]. | 1996 | Pathol. Biol. | pmid:8763594 |
| Tankovic J et al. | Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy. | 2001 | Pathol. Biol. | pmid:11642014 |
| Okiyama Y et al. | Helicobacter heilmannii infection: clinical, endoscopic and histopathological features in Japanese patients. | 2005 | Pathol. Int. | pmid:15982214 |
| Chang WJ et al. | Successful salvage treatment of steroid-refractory bronchiolar COP with low-dose macrolides. | 2012 | Pathol. Int. | pmid:22243785 |
| Suzuki T et al. | Localization of antigen-presenting cells in Helicobacter pylori-infected gastric mucosa. | 2002 | Pathol. Int. | pmid:12031081 |
| Schulz S et al. | Molecular diagnosis of a Mycobacterium chelonae infection. | 2001 | Pathol. Res. Pract. | pmid:11261816 |
| Grove DI and Koutsouridis G | Increasing resistance of Helicobacter pylori to clarithromycin: is the horse bolting? | 2002 | Pathology | pmid:11902451 |
| Grove DI et al. | Comparison of culture, histopathology and urease testing for the diagnosis of Helicobacter pylori gastritis and susceptibility to amoxycillin, clarithromycin, metronidazole and tetracycline. | 1998 | Pathology | pmid:9643503 |
| Midolo PD et al. | Antimicrobial resistance testing of Helicobacter pylori: a comparison of Etest and disk diffusion methods. | 1997 | Pathology | pmid:9423225 |
| McLean S and Sheikh A | Effectiveness, tolerability and safety of azithromycin 1% in DuraSite for acute bacterial conjunctivitis. | 2010 | Patient Prefer Adherence | pmid:20517467 |
| Zhang XR et al. | Pharmacokinetics of clarithromycin citrate salt after oral administration to beagle dogs and food effects on its absorption. | 2008 Nov-Dec | PDA J Pharm Sci Technol | pmid:19634347 |
| Koutsoubari I et al. | Effect of clarithromycin on acute asthma exacerbations in children: an open randomized study. | 2012 | Pediatr Allergy Immunol | pmid:22433020 |
| Akelma AZ et al. | Clarithromycin in treatment of acute asthma exacerbations: principles of appropriate antibiotic use. | 2012 | Pediatr Allergy Immunol | pmid:22984834 |
| Novembre E et al. | Systemic treatment of rhinosinusitis in children. | 2007 | Pediatr Allergy Immunol | pmid:17767611 |
| Andrianov M et al. | A 15-year-old boy with abdominal pain, growth retardation, and anemia secondary to Helicobacter pylori-associated peptic ulcer. | 2015 | Pediatr Ann | pmid:25806733 |
| Russo G et al. | Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study. | 2011 | Pediatr Blood Cancer | pmid:20830773 |
| van Doorn HR et al. | Widened coronary arteries in a feverish child. | 2006 Jul-Aug | Pediatr Cardiol | pmid:16830076 |
| Mytinger JR et al. | Henoch-Schönlein purpura associated with Helicobacter pylori infection in a child. | 2008 Nov-Dec | Pediatr Dermatol | pmid:19067870 |
| Nanda S et al. | Multidrug-resistant cutaneous tuberculosis: response to therapy. | 2003 Nov-Dec | Pediatr Dermatol | pmid:14651584 |
| Martire B et al. | Persistent B-cell lymphopenia, multiorgan disease, and erythema multiforme caused by Mycoplasma pneumoniae infection. | 2005 Nov-Dec | Pediatr Dermatol | pmid:16354262 |
| Bilgili SG et al. | Phototoxic dermatitis due to Chenopodium album in a child. | 2011 Nov-Dec | Pediatr Dermatol | pmid:21854411 |
| Lindeboom JA | Facial Skin Lesions in Children Caused by Nontuberculous Mycobacteria. | Pediatr Dermatol | pmid:26823205 | |
| Brantley JS et al. | Cutaneous Infection with Mycobacterium abscessus in a child. | 2006 Mar-Apr | Pediatr Dermatol | pmid:16650219 |
| Jang HS et al. | Successful treatment of localized cutaneous infection caused by Mycobacterium scrofulaceum with clarithromycin. | 2005 Sep-Oct | Pediatr Dermatol | pmid:16191006 |
| Kurekci AE et al. | Complete platelet recovery after treatment of Helicobacter pylori infection in a child with chronic immune thrombocytopenic purpura: a case report. | 2004 Oct-Nov | Pediatr Hematol Oncol | pmid:15626015 |
| Bay A et al. | Helicobacter pylori infection-related pancytopenia in a young boy. | 2011 | Pediatr Hematol Oncol | pmid:21728722 |
| Hayashi H et al. | Helicobacter pylori infection in children with chronic idiopathic thrombocytopenic purpura. | 2005 | Pediatr Int | pmid:15910453 |
| Ciftçi E et al. | Investigation of risk factors for tonsillopharyngitis with macrolide resistant Streptococcus pyogenes in Turkish children. | 2002 | Pediatr Int | pmid:12421263 |
| Kato S and Fujimura S | Primary antimicrobial resistance of Helicobacter pylori in children during the past 9 years. | 2010 | Pediatr Int | pmid:19563459 |
| Suzuki R et al. | Sinobronchial syndrome treated as intractable asthma. | 2018 | Pediatr Int | pmid:30320426 |
| Okuda M et al. | Nationwide survey of Helicobacter pylori treatment for children and adolescents in Japan. | 2017 | Pediatr Int | pmid:27223686 |
| Nishio N et al. | Cat scratch disease with encephalopathy in a 9-year-old girl. | 2008 | Pediatr Int | pmid:19067901 |
| Defilippi AC et al. | Changes in blood eosinophil numbers during Mycoplasma pneumoniae infection in wheezing and non-wheezing, atopic and non-atopic children. | 2008 | Pediatr Int | pmid:19261132 |
| Sasaoka Y et al. | Neonatal apnea with Chlamydia pneumoniae infection. | 2017 | Pediatr Int | pmid:28102626 |
| Wiedermann BL | Macrolides: clarithromycin and azithromycin. | 1998 | Pediatr Rev | pmid:9654947 |
| Woo MS et al. | Pediatric transplant grand rounds. A case presentation: skin lesions in a post-lung transplant patient. | 1997 | Pediatr Transplant | pmid:10084776 |
| Kalman S et al. | Mycoplasma pneumoniae infection in a child after renal transplantation. | 2004 | Pediatr Transplant | pmid:15367286 |
| Cohen M et al. | Histologic findings in "ex- Helicobacter pylori" gastric biopsies of pediatric patients. | 2005 Jul-Aug | Pediatr. Dev. Pathol. | pmid:16010501 |
| von König CH | Use of antibiotics in the prevention and treatment of pertussis. | 2005 | Pediatr. Infect. Dis. J. | pmid:15876929 |
| Syrogiannopoulos GA et al. | High prevalence of erythromycin resistance of Streptococcus pyogenes in Greek children. | 2001 | Pediatr. Infect. Dis. J. | pmid:11734765 |
| Baughman AL and Bisgard KM | Need for equivalence testing of efficacy of alternative antibiotics for treatment of pertussis. | 2003 | Pediatr. Infect. Dis. J. | pmid:12586986 |
| Petersen JP et al. | Community outbreak of perianal group A streptococcal infection in Denmark. | 2003 | Pediatr. Infect. Dis. J. | pmid:12586971 |
| Block S et al. | Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. | 1995 | Pediatr. Infect. Dis. J. | pmid:7667050 |
| Lopes AI et al. | Antibiotic-resistant Helicobacter pylori strains in Portuguese children. | 2005 | Pediatr. Infect. Dis. J. | pmid:15876938 |
| Nightingale CH | Pharmacokinetics and pharmacodynamics of newer macrolides. | 1997 | Pediatr. Infect. Dis. J. | pmid:9109156 |
| Tarlow MJ et al. | Future indications for macrolides. | 1997 | Pediatr. Infect. Dis. J. | pmid:9109159 |
| Green PA et al. | Mycobacterium avium complex parotid lymphadenitis: successful therapy with clarithromycin and ethambutol. | 1993 | Pediatr. Infect. Dis. J. | pmid:8346008 |
| Syrogiannopoulos GA et al. | Two dosages of clarithromycin for five days, amoxicillin/clavulanate for five days or penicillin V for ten days in acute group A streptococcal tonsillopharyngitis. | 2004 | Pediatr. Infect. Dis. J. | pmid:15361727 |
| Yang YJ et al. | Prevalence and rapid identification of clarithromycin-resistant Helicobacter pylori isolates in children. | 2001 | Pediatr. Infect. Dis. J. | pmid:11465837 |
| Guay DR and Craft JC | Overview of the pharmacology of clarithromycin suspension in children and a comparison with that in adults. | 1993 | Pediatr. Infect. Dis. J. | pmid:8295810 |
| Hebert AA et al. | Comparative safety and efficacy of clarithromycin and cefadroxil suspensions in the treatment of mild to moderate skin and skin structure infections in children. | 1993 | Pediatr. Infect. Dis. J. | pmid:8295811 |
| Pukander JS et al. | Clarithromycin vs. amoxicillin suspensions in the treatment of pediatric patients with acute otitis media. | 1993 | Pediatr. Infect. Dis. J. | pmid:8295812 |
| Still JG et al. | Comparison of clarithromycin and penicillin VK suspensions in the treatment of children with streptococcal pharyngitis and review of currently available alternative antibiotic therapies. | 1993 | Pediatr. Infect. Dis. J. | pmid:8295815 |
| Craft JC and Siepman N | Overview of the safety profile of clarithromycin suspension in pediatric patients. | 1993 | Pediatr. Infect. Dis. J. | pmid:8295816 |
| Klein JO | Clarithromycin: where do we go from here? | 1993 | Pediatr. Infect. Dis. J. | pmid:8295817 |
| Hardy DJ | Extent and spectrum of the antimicrobial activity of clarithromycin. | 1993 | Pediatr. Infect. Dis. J. | pmid:8295818 |
| Bradley JS et al. | Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia. | 2007 | Pediatr. Infect. Dis. J. | pmid:17901791 |
| Kuhn SM et al. | Treatment of Mycobacterium marinum facial abscess using clarithromycin. | 1995 | Pediatr. Infect. Dis. J. | pmid:7567299 |
| Lederer J et al. | Clarithromycin treatment of posttraumatic Mycobacterium fortuitum wound infection. | 1993 | Pediatr. Infect. Dis. J. | pmid:8414785 |
| Lebel MH and Mehra S | Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis: a prospective, randomized, single blind trial. | 2001 | Pediatr. Infect. Dis. J. | pmid:11740322 |
| Dierig A et al. | Antibiotic treatment of pertussis: are 7 days really sufficient? | 2015 | Pediatr. Infect. Dis. J. | pmid:25247586 |
| Steele RW et al. | Compliance issues related to the selection of antibiotic suspensions for children. | 2001 | Pediatr. Infect. Dis. J. | pmid:11176558 |
| Klein JO | History of macrolide use in pediatrics. | 1997 | Pediatr. Infect. Dis. J. | pmid:9109154 |
| Klein JO | Clarithromycin and azithromycin. | 1998 | Pediatr. Infect. Dis. J. | pmid:9655546 |
| Al Soub H et al. | Myocardial abscess and bacteremia complicating Mycobacterium fortuitum pacemaker infection: case report and review of the literature. | 2009 | Pediatr. Infect. Dis. J. | pmid:19859019 |
| McCracken GH | Microbiologic activity of the newer macrolide antibiotics. | 1997 | Pediatr. Infect. Dis. J. | pmid:9109155 |
| Ferguson PJ and Saulsbury FT | Successful treatment of chronic Mycobacterium abscessus otitis media with clarithromycin. | 1996 | Pediatr. Infect. Dis. J. | pmid:8866816 |
| Freyne B and Curtis N | Mycobacterium gordonae Skin Infection in an Immunocompetent Child. | 2017 | Pediatr. Infect. Dis. J. | pmid:28403059 |
| Shimizu T et al. | Case of intrafamilial Helicobacter pylori reinfection after successful eradication therapy. | 2000 | Pediatr. Infect. Dis. J. | pmid:11001123 |
| Reid R et al. | Pneumococcal meningitis during therapy of otitis media with clarithromycin. | 1995 | Pediatr. Infect. Dis. J. | pmid:8786899 |
| Mason EO et al. | Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes. | 2003 | Pediatr. Infect. Dis. J. | pmid:12867838 |
| Lindeboom JA et al. | Esthetic outcome of surgical excision versus antibiotic therapy for nontuberculous mycobacterial cervicofacial lymphadenitis in children. | 2009 | Pediatr. Infect. Dis. J. | pmid:19773678 |